[Treatment of chronic connective tissue diseases with cytostatics].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000008:administration & dosage; D002699:Chlorambucil / Q000008:administration & dosage; D002908:Chronic Disease; D003095:Collagen Diseases / Q000188:drug therapy* / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D013852:Thiotepa / Q000008:administration & dosage; D014228:Triaziquone / Q000008:administration & dosage
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D013852:Thiotepa; D011239:Prednisolone; D015122:Mercaptopurine; D014228:Triaziquone; D001379:Azathioprine; D008727:Methotrexate
Il trattamento delle malattie croniche del tessuto connettivo con i citostatici.